Abstract:BACKGROUND AND OBJECTIVE:The effectiveness of adjuvant chemotherapy in providing survival advantage for stage I non-small cell lung cancer (NSCLC) patients, especially those with stage Ib NSCLC, remains to be determined. The seventh edition of the Tumor Node Metastasis (TNM) Classification of Malignant Tumors is due to be published in 2009. The aim of the current study is to validate the value of this classification in Chinese early-stage NSCLC. The benefits of adjuvant chemotherapy to patients with early-stage NSCLC were also assessed.METHODS:The new staging project was validated in 433 patients who underwent complete surgical resection for early-stage NSCLC at the Single Institution of Shanghai Chest Hospital from June 1998 to June 2010. This new parameter was combined with other well-established prognostic factors, and multivariate survival analysis were performed. Variables in the analysis included age, gender, history of smoking, pathologic type, type of resection (pneumonectomy, lobectomy, bilobectomy, and sleeve resection), tumor size (largest tumor dimension), T-status, lymphovascular vessel invasion, and adjuvant chemotherapy.RESULTS:The three-year overall survival rates for females and males are 89.22% and 77.53%, respectively (P=0.001,8). Elder patients have worse prognoses: the survival rates for those aged ≥70 and <70 are 70.64% and 85.85%, respectively (P=0.000,1). The three-year overall survival rates of patients whose tumors measured no larger than 2 cm in biggest diameter or larger than 2 cm but no larger than 3 cm are 95.15% and 85.71%, respectively. For those with tumors larger than 3 cm but smaller than 5 cm or larger than 5 cm but smaller than 7 cm, the survival rates are 74.80% and 60.47%, respectively (P<0.000,1). Multivariate analysis reveals that age, gender, vascular vessel invasion, pathologic type, and visceral pleural involvement are significant predictive factors of the overall survival.CONCLUSIONS:The tumor size and pathologic type are significant independent prognostic factors in stage I NSCLC. The survival rates of patients with adenocarcinoma are higher than those of patients with other types of NSCLC. Female patients and those without a history of smoking have a better outcome. Results suggest that patients with the Ib stage of the disease can benefit from adjuvant chemotherapy.

Survival Analysis of 220 Patients with Completely Resected Stage-Ii Non-Small Cell Lung Cancer

[Survival Analysis of Completely Resected Stage IIIB Non-Small Cell Lung Cancer].

[Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].

Survival Analysis of Non-Small Cell Lung Cancer Patients with Adjuvant Chemotherapy.

[Multivariate Survival Analysis for 423 Patients with Non-Small Cell Lung Cancer].

Survival and prognostic factors in completely resected ⅢA-N_2 non-small cell lung cancer:208 cases study

Multivariate Survival Analysis of Patients with Stage I NSCLC

Survival Analysis for 131 Patients with Non-Small Cell Lung Cancer after Resection

Real-world Surgical Treatment Patterns and Clinical Outcomes in Patients with Stages IA–IIIA Non-Small Cell Lung Cancer: a Retrospective Multicentric Observational Study Involving 11,958 Patients

[Prognostic Analysis of Curative Surgery for Stage IIIA-N2 Non-Small Cell Lung Cancer].

[Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients Treated with Surgery].

Survival and Progostic Factors in Resected ⅢA-N2 Non-small Cell Lung Cancer : A Study of 288 Cases

Survival Analysis of Patients with Non-Small Cell Lung Cancer Who Underwent Surgical Resection Following 4 Lung Cancer Resection Guidelines.

Analysis of survival after complete resection of stageⅢA-N2 non-small cell lung cancer

The prognosis of completed resectable ⅢA non-small cell lung cancer and the suggestion of the treatment strategy

Treatment and Prognostic Analysis of 1638 Patients with Non-Small Cell Lung Cancer

Prognostic influencing factors in stage ⅠB non-small cell lung cancer

The role of surgery in the management and prognosis of limited-stage Ⅱ small cell lung cancer

Analysis of the Prognostic Factors in Resection of 181 Patients with Adenosquamous Lung Carcinoma

Clinical Analysis of Sixty-Four Patients with T1an2m0 Stage Non-Small Cell Lung Cancer Who Had Undergone Resection

P3-246: Prognostic Influencing Factors in Stage IB Non-Small Cell Lung Cancer